04 September 2010
Keywords: Astellas, immunosuppressants, FDA, tacrolimus
Article | 14 September 2009
The US District Court in Washington DC has denied the Temporary Restraining Order and Preliminary Injunction requested by Japanese drug major Astellas’ local subsidiary to stop the Food and Drug Administration from approving generic versions of oral immunosuppressant drugs.
T Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.
FREE unlimited, no obligation access to The Pharma Letter website for 30 days, normally worth £60!
Sign up in less than 60 seconds...no payment needed
Take a no obligations 30 day trial.
Only one trial per user. Find out more details
Subscriptions are £60 per month, pay as you go.
Find out more details.